#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16384	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2056	791.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1443	1443	C	1010	C	928	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16384	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2056	791.5	0	HET	.	.	.	C207T	.	207	207	C	466	466	C	898	C,T	649,173	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16384	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2056	791.5	0	HET	.	.	.	C451T	.	451	451	C	710	710	C	957	C,T	676,199	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16384	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2056	791.5	0	HET	.	.	.	G1413T	.	1413	1413	G	1672	1672	G	911	G,T	631,201	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29088	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	807.8	0	.	n	.	0	T695C	SNP	695	695	T	1039	1039	C	912	C	821	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29088	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	807.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1982	1982	G	904	G,A	633,208	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29088	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	807.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2315	2315	C	945	C,T	853,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29088	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	807.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2389	2389	A	913	A	836	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29088	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	807.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2941	2941	C	881	C,G,A	806,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2092	folP	855	855	100.0	folP.l15.c4.ctg.1	1596	130.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1055	1057	AGC	230;231;234	A;G;C	213;212;212	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6068	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3346	180.3	1	SNP	p	S91F	1	.	.	271	273	TTC	544	546	TTC	205;208;207	T;T;C	191;191;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6068	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3346	180.3	1	SNP	p	D95G	1	.	.	283	285	GGC	556	558	GGC	202;205;202	G;G;C	185;188;185	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6068	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3346	180.3	1	SNP	p	G95N	0	.	.	283	285	GGC	556	558	GGC	202;205;202	G;G;C	185;188;185	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1746	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1376	126.6	1	SNP	p	G45D	0	.	.	133	135	GGC	499	501	GGC	254;256;256	G;G;C	229;229;226	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	912	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	965	94.1	0	.	n	.	0	A197.	DEL	197	197	A	584	584	A	223	A	208	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5932	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2864	206.1	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	217;218;220	G;A;C	203;199;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5932	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2864	206.1	1	SNP	p	R87W	0	.	.	259	261	CGT	545	547	CGT	218;221;222	C;G;T	202;205;205	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5932	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2864	206.1	1	SNP	p	R87I	0	.	.	259	261	CGT	545	547	CGT	218;221;222	C;G;T	202;205;205	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5932	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2864	206.1	1	SNP	p	S87R	1	.	.	259	261	CGT	545	547	CGT	218;221;222	C;G;T	202;205;205	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5932	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2864	206.1	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	225;226;232	T;C;C	210;207;213	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4572	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2584	175.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1583	1585	GGC	223;224;222	G;G;C	205;206;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1135	1137	GCC	245;247;249	G;C;C	226;224;225	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1138	1140	ATG	251;250;250	A;T;G	229;229;227	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1150	1152	ACC	249;247;246	A;C;C	228;230;229	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1150	1152	ACC	249;247;246	A;C;C	228;230;229	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1651	1653	ACC	207;205;204	A;C;C	191;192;191	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1705	1707	GCG	219;222;221	G;C;G	199;201;200	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1705	1707	GCG	219;222;221	G;C;G	199;201;200	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1828	1830	GGT	182;185;184	G;G;T	170;175;171	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1837	1839	AGC	179;179;178	A;G;C	166;163;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2211	193.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1855	1857	CCG	161;162;159	C,G;C,G;G	104,9;109,1;112	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6242	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3025	205.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1508	1510	CCG	211;210;210	C;C;G	186;191;184	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2434	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1778	136.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	155	C	141	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	308	90.71	porB1a.l6.c30.ctg.2	353	31.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	70	72	AAT	19;19;19	A;A;T	18;17;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	308	90.71	porB1a.l6.c30.ctg.2	353	31.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	73	75	AAT	20;20;20	A;A;T	19;19;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	308	90.71	porB1a.l6.c30.ctg.2	353	31.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	97	99	GCA	23;23;24	G;C;A	23;23;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	308	90.71	porB1a.l6.c30.ctg.2	353	31.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	120	122	GTA	21;21;21	G;T;A	21;20;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	336	porB1a	984	308	90.71	porB1a.l6.c30.ctg.2	353	31.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	129	129	A	18	A	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1813	170.5	0	.	p	.	0	G210R	NONSYN	628	630	GGA	975	977	AGA	264;263;263	A;G;A	241;236;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1813	170.5	0	.	p	.	0	S217G	NONSYN	649	651	AGT	996	998	GGT	268;269;269	G;G,T;T	248;247,1;246	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1813	170.5	1	SNP	p	G120K	1	.	.	358	360	AAG	705	707	AAG	268;268;269	A;A;G	247;248;243	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1813	170.5	1	SNP	p	N121D	0	.	.	361	363	AAC	708	710	AAC	265;263;263	A;A;C,A	244;240;241,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3102	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1813	170.5	1	SNP	p	A121N	1	.	.	361	363	AAC	708	710	AAC	265;263;263	A;A;C,A	244;240;241,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11592	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4927	234.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1140	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	949	118.9	1	SNP	p	V57M	1	.	.	169	171	ATG	477	479	ATG	239;238;239	A;T;G,A	224;222;221,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
